Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does etomidate cause haemolysis?

A E Nebauer1, A Doenicke, R Hoernecke

  • 1Institut für Anaesthesiologie, Ludwig-Maximilians-Universität München, Germany.

British Journal of Anaesthesia
|July 1, 1992
PubMed
Summary

Etomidate in propylene glycol causes red blood cell damage, indicated by decreased haptoglobin levels. Lipid emulsion is a safer alternative, showing no significant cell damage in this study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remifentanil and fentanyl during anaesthesia for major abdominal and gynaecological surgery. An open, comparative study of safety and efficacy.

European journal of anaesthesiology·2001
Same author

[Nausea and vomiting after anesthesia: possibly not a "never ending story"?].

Der Anaesthesist·2000
Same author

Causality-based diagnosis of histamine-related cardiorespiratory disturbances in surgical patients.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·1998
Same author

[Optimizing preparation for surgical intervention].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·1998
Same author

Haemolysis after etomidate: comparison of propylene glycol and lipid formulations.

British journal of anaesthesia·1997
Same author

[Cisatracurium--is the stereoisomer an "ideal" relaxant? Histamine liberation and tryptase determination after bolus administration of cistracurium: a comparison with vecuronium].

Der Anaesthesist·1997

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Hematology

Background:

  • Etomidate is commonly formulated with propylene glycol, a solvent with high osmolality.
  • High osmolality solvents may contribute to adverse drug effects, including hemolysis.
  • Haptoglobin is a biomarker for red blood cell damage.

Purpose of the Study:

  • To investigate the hemolytic potential of etomidate formulated in propylene glycol versus lipid emulsion.
  • To compare the effects of different etomidate formulations on serum haptoglobin levels.

Main Methods:

  • 12 healthy male volunteers received etomidate (0.3 mg/kg).
  • Six subjects received etomidate in propylene glycol (EtoPG, 4965 mosmol/kg).
  • Six subjects received etomidate in lipid emulsion (EtoLip, 400 mosmol/kg).
  • Serum haptoglobin concentrations were measured at baseline, 2, 4, and 24 hours post-administration.

Main Results:

  • Serum haptoglobin decreased by 44% and 43% at 2 and 4 hours in the EtoPG group.
  • Haptoglobin reductions in the EtoPG group were significantly lower compared to the EtoLip group.
  • Haptoglobin levels did not return to baseline within 24 hours in the EtoPG group.

Conclusions:

  • Etomidate formulated in propylene glycol induces significant hemolysis in healthy volunteers.
  • Lipid emulsion is a safer vehicle for etomidate administration, minimizing red blood cell damage.
  • Alternative formulations to propylene glycol are recommended for etomidate to reduce adverse effects.

Related Experiment Videos